OCON Therapeutics

About OCON Therapeutics

OCON Therapeutics is dedicated to introducing innovative, high-quality intrauterine drug-delivery technology to improve and impact women's health and quality of life. Their mission focuses on designing products specifically for women, managed by women, to fit female anatomy and needs.

Products & Services

IUB(r) Ballerine(r):A safer, hormone-free next-generation 'smart' IUD (long-acting reversible contraceptive) that fits women's anatomy.

IUB(r) SEAD(r) (Spherical Endometrial Ablation Device):A novel, once-and-done, pain-free, and safe solution for the treatment of Abnormal Uterine Bleeding (AUB) and Heavy Menstrual Bleeding (HMB).

IUB(r) PRIMA(r):A therapeutic delivery system targeting therapy areas such as endometriosis, myomas, heavy menstrual bleeding, and other hormonal solutions, delivered directly through the uterus to avoid systemic side effects.

Specialties

Intrauterine drug-delivery technology Women's health solutions Hormone-free contraception Endometrial ablation devices Therapeutic delivery for gynecological conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment Round T: - FT: Investment Round	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2024-06-24 FD: 2024-06-24	6 investors

Investment Round Latest

2024-06-24

$10.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Ilan Baram

Senior Gynecologist and Inventor

K

Keren Leshem

Chief Executive Officer

LinkedIn (Pro only)

A

Amir Avraham

CFO & General Manager

LinkedIn (Pro only)

D

Daniela Schardinger

VP Marketing & Medical Affairs

A

Adely Levy

VP RA/QA

S

Susan Alpert

Senior Regulatory Advisor

View 16 more team members with Pro

Unlock Full Team Directory

Recent News